John Ackerman's Insider Trades & SAST Disclosures
John Ackerman's most recent trade in Guardian Pharmacy Services Inc. - Ordinary Shares - Class A was a trade of 813,318 Class A Common Stock done at an average price of $20.2 . Disclosure was reported to the exchange on May 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Ackerman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardian Pharmacy Services... | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 813,318 | 600,622 | - | 20.2 | 16,396,491 | Class A Common Stock |
| Guardian Pharmacy Services... | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 270,958 | 200,099 | - | 20.2 | 5,462,513 | Class A Common Stock |
| Guardian Pharmacy Services... | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 150,998 | 449,624 | - | 20.2 | 3,044,120 | Class A Common Stock |
| Guardian Pharmacy Services... | John Ackerman | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 27 May 2025 | 50,305 | 149,794 | - | 20.2 | 1,014,149 | Class A Common Stock |
| Guardian Pharmacy Services... | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 1,413,940 | 4,241,818 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services... | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 1,413,940 | 1,413,940 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services... | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 471,057 | 471,057 | - | - | Class A Common Stock | |
| Guardian Pharmacy Services... | John Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 471,057 | 1,413,171 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services... | John Ackerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 5,655,758 | 5,655,758 | - | - | Class B Common Stock | |
| Guardian Pharmacy Services... | John Ackerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 1,884,228 | 1,884,228 | - | - | Class B Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges